The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium

Anesthesiology

Volumn 92, Issue 6, 2000, Pages 1581-1587

  Østergaard, Doris ^a   Rasmussen, Søren N ^b   Viby Mogensen, Jørgen ^c   Pedersen, Niels A ^c   Boysen, Rikke ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Butyrylcholinesterase; Enzymes; Metabolites; Neuromuscular relaxants; Pseudocholinesterase; Stereoisomers

Indexed keywords

BAMBUTEROL; CHOLINESTERASE; DIAZEPAM; FENTANYL; MIVACURIUM; NITROUS OXIDE; PROPOFOL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CHOLINESTERASE INHIBITION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG POTENCY; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MYOGRAPHY; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

EID: 0034086182     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200006000-00014     Document Type: Article

References (20)

1. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RPF, Sunder N, Weakly JN, Wastila WB, El-Sayad HA: The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). ANESTHESIOLOGY 1988; 68:723-32
2. Cook DR, Stiller RL, Weakly JN, Chakravorti S, Brandom BW, Welch RM: In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 1989; 68:452-6
3. Østergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby Mogensen J: Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 1992; 36:702-6
4. Head-Rapson AG, Devlin JC, Parker CJR, Hunter JM: Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. Br J Anaesth 1995; 75:31-6
5. Devlin JC, Head-Rapson AG, Parker CJR, Hunter JM: Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Br J Anaesth 1993; 71:227-31
6. Head-Rapson AG, Devlin JC, Parker CJR, Hunter JM: Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. Br J Anaesth 1994; 73:613-8
7. Olsson OAT, Svensson LÅ: New lipophilic terbutaline ester prodrugs with long effect duration. Pharm Res 1984; 1:19-23
8. Svensson LÅ, Tunek A: The design and bioactivation of presystemically stable products. Drugs Metab Rev 1988; 19:165-94
9. Fisher DM, Caldwell JE, Sharma M, Wirén JE: The influence of bambuterol (carbamylated terbutaline) on the duration of action of succinylcholine-induced paralysis in humans. ANESTHESIOLOGY 1988; 69(5):757-9
10. Bang U, Viby Mogensen J, Wirén JE, Skovgaard LT: The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients. Acta Anaesthesiol Scand 1990; 34:596-9
11. Staun P, Lennmarken C, Eriksson LI, Wire'n JE: The influence of 10 mg and 20 mg of bambuterol on the duration of succinylcholine induced neuromuscular blockade. Acta Anaesthesiol Scand 1990; 34:498-500
12. Jensen FS, Skovgaard LT, Viby-Mogensen J: Identification of human plasma cholinesterase variants in 6.688 individuals using biochemical analysis. Acta Anaesthesiol Scand 1995; 39:157-62
13. Viby Mogensen J, Engbæk J, Eriksson LI, Gramstad L, Jensen E, Jensen FS, Koscielniak-Nielsen Z, Skovgaard LT, Østergaard D: Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40:59-74
14. DÁrgenio DZ, Schumitzky A: ADAPT II User's guide. Los Angeles, Biomedical Simulation Resources, University of Southern California, 1992
15. Caldwell JE, Heier T, Kitts JB, Lynam DP, Fahey MR, Miller RD: Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia. Br J Anaesth 1989; 63:393-9
16. Kopmun AF, Mallhi MU, Justo MD, Rodricks P, Neuman GG: Antagonism of mivacurium-induced neuromuscular blockade in humans. ANESTHESIOLOGY 1994; 81:1394-1400
17. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ: The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. ANESTHESIOLOGY 1994; 80:1296-302
18. Lacroix M, Donati F, Varin F: Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration. ANESTHESIOLOGY 1997; 86:322-30
19. Markakis DA, Lau M, Brown R, Luks AM, Sharma ML, Fisher DM: The pharmacokinetics and steady state pharmacodynamics of mivacurium in children. ANESTHESIOLOGY 1998; 88:978-83
20. Ducharme J, Varin F, Bevan DR, Donati F: Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters. Clin Pharmacokinet 1993; 24:507-18